Mendelian randomisation study of body composition and depression in people of East Asian ancestry highlights potential setting-specific causality.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 18 05 2022
accepted: 12 01 2023
entrez: 2 2 2023
pubmed: 3 2 2023
medline: 4 2 2023
Statut: epublish

Résumé

Extensive evidence links higher body mass index (BMI) to higher odds of depression in people of European ancestry. However, our understanding of the relationship across different settings and ancestries is limited. Here, we test the relationship between body composition and depression in people of East Asian ancestry. Multiple Mendelian randomisation (MR) methods were used to test the relationship between (a) BMI and (b) waist-hip ratio (WHR) with depression. Firstly, we performed two-sample MR using genetic summary statistics from a recent genome-wide association study (GWAS) of depression (with 15,771 cases and 178,777 controls) in people of East Asian ancestry. We selected 838 single nucleotide polymorphisms (SNPs) correlated with BMI and 263 SNPs correlated with WHR as genetic instrumental variables to estimate the causal effect of BMI and WHR on depression using the inverse-variance weighted (IVW) method. We repeated these analyses stratifying by home location status: China versus UK or USA. Secondly, we performed one-sample MR in the China Kadoorie Biobank (CKB) in 100,377 participants. This allowed us to test the relationship separately in (a) males and females and (b) urban and rural dwellers. We also examined (c) the linearity of the BMI-depression relationship. Both MR analyses provided evidence that higher BMI was associated with lower odds of depression. For example, a genetically-instrumented 1-SD higher BMI in the CKB was associated with lower odds of depressive symptoms [OR: 0.77, 95% CI: 0.63, 0.95]. There was evidence of differences according to place of residence. Using the IVW method, higher BMI was associated with lower odds of depression in people of East Asian ancestry living in China but there was no evidence for an association in people of East Asian ancestry living in the USA or UK. Furthermore, higher genetic BMI was associated with differential effects in urban and rural dwellers within China. This study provides the first MR evidence for an inverse relationship between BMI and depression in people of East Asian ancestry. This contrasts with previous findings in European populations and therefore the public health response to obesity and depression is likely to need to differ based on sociocultural factors for example, ancestry and place of residence. This highlights the importance of setting-specific causality when using genetic causal inference approaches and data from diverse populations to test hypotheses. This is especially important when the relationship tested is not purely biological and may involve sociocultural factors.

Sections du résumé

BACKGROUND
Extensive evidence links higher body mass index (BMI) to higher odds of depression in people of European ancestry. However, our understanding of the relationship across different settings and ancestries is limited. Here, we test the relationship between body composition and depression in people of East Asian ancestry.
METHODS
Multiple Mendelian randomisation (MR) methods were used to test the relationship between (a) BMI and (b) waist-hip ratio (WHR) with depression. Firstly, we performed two-sample MR using genetic summary statistics from a recent genome-wide association study (GWAS) of depression (with 15,771 cases and 178,777 controls) in people of East Asian ancestry. We selected 838 single nucleotide polymorphisms (SNPs) correlated with BMI and 263 SNPs correlated with WHR as genetic instrumental variables to estimate the causal effect of BMI and WHR on depression using the inverse-variance weighted (IVW) method. We repeated these analyses stratifying by home location status: China versus UK or USA. Secondly, we performed one-sample MR in the China Kadoorie Biobank (CKB) in 100,377 participants. This allowed us to test the relationship separately in (a) males and females and (b) urban and rural dwellers. We also examined (c) the linearity of the BMI-depression relationship.
RESULTS
Both MR analyses provided evidence that higher BMI was associated with lower odds of depression. For example, a genetically-instrumented 1-SD higher BMI in the CKB was associated with lower odds of depressive symptoms [OR: 0.77, 95% CI: 0.63, 0.95]. There was evidence of differences according to place of residence. Using the IVW method, higher BMI was associated with lower odds of depression in people of East Asian ancestry living in China but there was no evidence for an association in people of East Asian ancestry living in the USA or UK. Furthermore, higher genetic BMI was associated with differential effects in urban and rural dwellers within China.
CONCLUSIONS
This study provides the first MR evidence for an inverse relationship between BMI and depression in people of East Asian ancestry. This contrasts with previous findings in European populations and therefore the public health response to obesity and depression is likely to need to differ based on sociocultural factors for example, ancestry and place of residence. This highlights the importance of setting-specific causality when using genetic causal inference approaches and data from diverse populations to test hypotheses. This is especially important when the relationship tested is not purely biological and may involve sociocultural factors.

Identifiants

pubmed: 36726144
doi: 10.1186/s12916-023-02735-8
pii: 10.1186/s12916-023-02735-8
pmc: PMC9893684
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Subventions

Organisme : Cancer Research UK
ID : C16077/A29186
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT220390
Pays : United Kingdom
Organisme : UK Medical Research Council
ID : MR/M020894/1
Organisme : Wellcome Trust
ID : 088158/Z/09/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104085/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC-PC-14135
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U137686851
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00017/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212946/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC-PC-13049
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1996001/9454
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202922/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12026/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT104150
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C500/A16896
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14135
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Chin Med J (Engl). 2015 Sep 20;128(18):2462-6
pubmed: 26365963
BMJ. 2018 Jul 12;362:k601
pubmed: 30002074
Biomed Environ Sci. 2002 Sep;15(3):245-52
pubmed: 12500665
Am J Epidemiol. 2011 Feb 15;173(4):421-9
pubmed: 21248310
Stat Methods Med Res. 2017 Oct;26(5):2333-2355
pubmed: 26282889
Aging Ment Health. 2017 May;21(5):518-523
pubmed: 26689763
Health Psychol. 2015 Feb;34(2):172-5
pubmed: 25133837
Sci Rep. 2016 Sep 07;6:32730
pubmed: 27601421
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Obes Rev. 2012 Nov;13(11):1067-79
pubmed: 22764734
Hum Mol Genet. 2021 Nov 30;30(24):2371-2382
pubmed: 34270736
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Biomed Environ Sci. 2002 Mar;15(1):83-96
pubmed: 12046553
JAMA Psychiatry. 2021 Nov 1;78(11):1258-1269
pubmed: 34586374
Nat Genet. 2017 Oct;49(10):1458-1467
pubmed: 28892062
Int J Epidemiol. 2019 Jun 1;48(3):834-848
pubmed: 30423117
Global Health. 2018 Feb 13;14(1):20
pubmed: 29439728
Chang Gung Med J. 2011 Nov-Dec;34(6):620-7
pubmed: 22196065
Am J Epidemiol. 2007 Sep 15;166(6):646-55
pubmed: 17615092
Transl Psychiatry. 2019 Aug 5;9(1):184
pubmed: 31383844
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
J Womens Health (Larchmt). 2009 Aug;18(8):1121-2
pubmed: 19627236
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
BMJ. 2006 Aug 19;333(7564):362-3
pubmed: 16916811
Int J Epidemiol. 2011 Dec;40(6):1652-66
pubmed: 22158673
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Int J Environ Res Public Health. 2017 Apr 19;14(4):
pubmed: 28422077
Econ Hum Biol. 2019 May;33:144-148
pubmed: 30877852
Mol Psychiatry. 2019 Jan;24(1):18-33
pubmed: 29453413
Body Image. 2006 Dec;3(4):395-400
pubmed: 18089243
PLoS One. 2018 Oct 16;13(10):e0205573
pubmed: 30325943
J Adolesc Health. 2006 Jun;38(6):675-83
pubmed: 16730595
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Br J Psychiatry. 2014 Jul;205(1):24-8
pubmed: 24809401
PLoS One. 2017 Aug 28;12(8):e0183881
pubmed: 28846742
Clin Nutr. 2020 Jul;39(7):2001-2013
pubmed: 31732288
BMC Public Health. 2016 Nov 29;16(1):1201
pubmed: 27894296
Sci Adv. 2020 Apr 15;6(16):eaay0328
pubmed: 32426451
Int J Obes Relat Metab Disord. 2004 Dec;28(12):1561-8
pubmed: 15278107
Br Med J. 1976 Jan 3;1(6000):7-9
pubmed: 1247732
Hum Mol Genet. 2019 Jan 1;28(1):166-174
pubmed: 30239722
BMC Public Health. 2009 Jan 13;9:14
pubmed: 19144098
J Acad Nutr Diet. 2016 Mar;116(3):458-466
pubmed: 26260670
Am J Epidemiol. 2003 Dec 15;158(12):1139-47
pubmed: 14652298

Auteurs

Jessica O'Loughlin (J)

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Francesco Casanova (F)

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Zammy Fairhurst-Hunter (Z)

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Amanda Hughes (A)

MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.

Jack Bowden (J)

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Edward R Watkins (ER)

Department of Psychology, University of Exeter, Exeter, UK.

Rachel M Freathy (RM)

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Iona Y Millwood (IY)

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
MRC Population Health Research Unit (PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Kuang Lin (K)

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Zhengming Chen (Z)

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
MRC Population Health Research Unit (PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Liming Li (L)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.

Jun Lv (J)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.

Robin G Walters (RG)

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
MRC Population Health Research Unit (PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Laura D Howe (LD)

MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.

Karoline Kuchenbaecker (K)

Division of Psychiatry, UCL Genetics Institute, University College London, London, UK.

Jessica Tyrrell (J)

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK. j.tyrrell@exeter.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH